Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients

By  

Current HIV Research, Vol. 15, Iss. 6, 2018-01 ,pp. : 448-455

Bentham Science Publishers

Access to resources Recommend Favorite

Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability

By Préau M.   Protopopescu C.   Raffi F.   Rey D.   Chêne G.   Marcellin F.   Perronne C.   Ragnaud J.M.   Leport C.   Spire B.    

AIDS Care, Vol. 24, Iss. 4, 2012-04 ,pp. : 434-443

Routledge Ltd

Access to resources Recommend Favorite

Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz

By  

Current HIV Research, Vol. 14, Iss. 1, 2016-01 ,pp. : 61-70

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 Residual Viremia and Proviral DNA in Patients with Suppressed Plasma Viral Load (<400 HIV-RNA cp/ml) During Different Antiretroviral Regimens

By  

Current HIV Research, Vol. 6, Iss. 3, 2008-05 ,pp. : 261-266

Bentham Science Publishers

Access to resources Recommend Favorite

Factors associated with discontinuation of antiretroviral therapy in HIV-infected patients with alcohol problems

By Kim T. W.   Palepu A.   Cheng D. M.   Libman H.   Saitz R.   Samet J. H.  

AIDS Care, Vol. 19, Iss. 8, 2007-09 ,pp. : 1039-1047

Routledge Ltd

Access to resources Recommend Favorite